"ID","biorxiv","published","title","year","journal","doi","author","author_name","author_email","author_address","hypothesis","rationale","MR_design","outcome","outcome_info","outcome_group","outcome_definition","outcome_study","outcome_age_range","outcome_sex","outcome_n_case_current","outcome_n_control_current","outcome_n_case_og","outcome_n_control_og","outcome_n_difference_reason","outcome_health_status","outcome_population","exposure","exposure_definition","exposure_study","exposure_age","exposure_sex","exposure_n_current","exposure_n_og","exposure_n_difference_reason","exposure_health_status","exposure_population","exposure_covariates_model","exposure_genotyping_dataset","exposure_independence","exposure_pleiotropy","exposure_pvalue","exposure_palindrome","exposure_proxy","exposure_HWE","IV_single","IV_multiple","IV_GRS","n_SNP_og","n_SNP_difference_reason","power_calculation","power_calculation_how","MR_method","MR_sensitivity_method1","MR_sensitivity_method2","MR_sensitivity_method3","MR_sensitivity_method4","MR_sensitivity_method5","MR_sensitivity_method_results","IV_strength","analysis_software","analysis_programme","replication_independent","replication_subsetting","multiple_testing","exposure_units","outcome_units","effect_estimate","estimate","se","ci_percent","ci_lower","ci_upper","p","adjustment_method","p_adjusted","limitations_overall","limitations_pleiotropy","limitations_population_stratification","limitations_statistical_power","notes","ID_analysis"
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"95","77","Said they used European SNPs but clearly using all ancestry SNPs - though 1 is missing which isn't discussed","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","MR Egger","Weighted median",NA,NA,NA,"Consistent with main analysis","Variance explaine from GWAS presented, 2.7%","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","case/control","OR","1.34",NA,"95","1.0900000000000001","1.65","6.6000000000000003E-2",NA,NA,"Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,162
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European, PanScan I both","18+","both","1788","1769","1788","1769",NA,"case/control","European, PanScan I","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"95","77","Said they used European SNPs but clearly using all ancestry SNPs - though 1 is missing which isn't discussed","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","MR Egger","Weighted median",NA,NA,NA,"Consistent with main analysis","Variance explaine from GWAS presented, 2.7%","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","case/control","OR","1.48",NA,"95","0.98","2.2400000000000002","0.06",NA,NA,"Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,163
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European, PanScan II both","18+","both","1696","1563","1696","1563",NA,"case/control","European, PanScan II","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"95","77","Said they used European SNPs but clearly using all ancestry SNPs - though 1 is missing which isn't discussed","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","MR Egger","Weighted median",NA,NA,NA,"Consistent with main analysis","Variance explaine from GWAS presented, 2.7%","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","case/control","OR","1.4",NA,"95","0.91","2.15","0.13",NA,NA,"Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,164
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European, PanC4 both","18+","both","3626","3632","3626","3632",NA,"case/control","European, PanC4","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"95","77","Said they used European SNPs but clearly using all ancestry SNPs - though 1 is missing which isn't discussed","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","MR Egger","Weighted median",NA,NA,NA,"Consistent with main analysis","Variance explaine from GWAS presented, 2.7%","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","case/control","OR","1.25",NA,"95","0.94","1.66","0.12",NA,NA,"Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,165
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European male","18+","male","3861","4056","3861","4056",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"95","77","Said they used European SNPs but clearly using all ancestry SNPs - though 1 is missing which isn't discussed","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","MR Egger","Weighted median",NA,NA,NA,"Consistent with main analysis","Variance explaine from GWAS presented, 2.7%","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","case/control","OR","1.35",NA,"95","1.02","1.78","0.04",NA,NA,"Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,166
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European female","18+","female","3252","3268","3252","3268",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"95","77","Said they used European SNPs but clearly using all ancestry SNPs - though 1 is missing which isn't discussed","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","MR Egger","Weighted median",NA,NA,NA,"Consistent with main analysis","Variance explaine from GWAS presented, 2.7%","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","case/control","OR","1.34",NA,"95","0.98","1.82","0.06",NA,NA,"Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,167
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"28","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Neuronal developmental processes","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","1.17",NA,"95","0.77","1.77","0.47","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,174
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"11","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Hypothalamic expression and regulatory function","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","1.27",NA,"95","0.81","1.98","0.31","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,175
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"11","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Neuronal Expression","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","1.41",NA,"95","0.72","2.76","0.32","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,176
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"10","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Lipid biosynthesis and metabolism","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","1.31",NA,"95","0.59","2.89","0.51","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,177
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"9","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Neurotransmission","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","1.9",NA,"95","0.1","3.95","0.09","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,178
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"8","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Bone development","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","2.34",NA,"95","1.03","5.32","0.04","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,179
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"8","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Mitogen activated protein kinase 1 Extracellular sinal regulated kinases","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","0.67",NA,"95","0.98","4.92","0.06","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,180
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"5","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in CyclicAMP","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","1.48",NA,"95","0.28999999999999998","1.53","0.34","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,181
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"5","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Wnt","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","1.34",NA,"95","0.75","2.92","0.25","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,182
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"19","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Cell cycle","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","1.87",NA,"95","0.77","2.31","0.3","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,183
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"13","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Endocytosis Exocytosis","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","1.73",NA,"95","1.01","3.68","0.05","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,184
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"13","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Immune system","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","1.29",NA,"95","0.98","3.58","0.06","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,185
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"12","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Apopotosis","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","1.37",NA,"95","0.84","3.59","0.14000000000000001","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,186
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"11","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Glucose homeostasis and or diabetes","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","1.29",NA,"95","0.71","2.36","0.41","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,187
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"11","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Membrane proteins","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","0.52",NA,"95","0.81","2.2999999999999998","0.24","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,188
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"10","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Tumorigenesis","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","0.76",NA,"95","0.63","2.6","0.49","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,189
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"7","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Mitochndrial","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","1.25",NA,"95","0.24","1.1100000000000001","0.09","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,190
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"7","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Monogenic Obesity and or Energy Homeostasis","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","1.43",NA,"95","0.42","1.4","0.38","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,191
22,"no","yes","The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study",2017,"Journal of the National Cancer Institute","10.1093/jnci/djx012","Carreras-Torres","Paul Brennan","gep@iarc.fr","Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France","Effect of body mass index on cancer","Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging.","Two-sample summary-level","pancreatic cancer","pancreatic cancer","cancer","Defined in individual GWASs","Carreeras-Torres 2017 Pancreatic cancer European both","18+","both","7110","7264","7110","7264",NA,"case/control","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","Not discussed","322154",NA,"Healthy","European",NA,NA,"Auhors state GWAS independence threshold. Do not do formal test.","Not discussed","5x10-8","Replaced with proxies or removed","Allowed for ambiguos strans but not discussed for other SNPs","Not discussed",NA,NA,"6","77","Said they used European SNPs but clearly using all ancestry SNPs - only included SNPs that clustered in Retinoic Acid Receptors","Yes","Power calculations on MR analyses were performed according to Burgess","Likelihood based method","Not discussed",NA,NA,NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni correction for 157 tests (tests included for other phenotypes such as height) = 3.2x10-4","SD","case/control","OR","1.1000000000000001",NA,"95","0.53","2.97","0.61","Bonferroni for 157 tests","3.2x10-4","Underpowered for WHR. Deviations from the MR assumptions would bias results to the null. Effects may not be reflective of the extremes of exposure distributions. ","MR Egger and weighted median did not show evidence of pleiotropy. Neither did funnel plots.","Not discussed","Not discussed, but sia dthey were underpowered for WHR",NA,192
54,"no","yes","Effect of increased body mass index on risk of diagnosis or death from cancer",2019,"British Journal of Cancer","10.1038/s41416-019-0386-9","Gharahkhani","Puya Gharahkhani","Puya.Gharahkhani@qimrberghofer.edu.au","QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia","Effect of BMI on overall cancer risk and cancer mortality","High BMI is strongly associated with increased risk of various cancers.","One-sample","pancreatic cancer","pancreatic cancer","cancer","C25","Puya Gharahkhani  2019 Pancreatic (C25) White-British both","40-69","both","500",NA,"500",NA,NA,"Pancreatic (C25)","White-British","BMI","BMI","Puya Gharahkhani  2019 BMI White British adults both",NA,"Both","390628","390628",NA,"Healthy (cancer-free)","White-British","Age and sex","HRC ","0.01","To assess this assumption, we repeated the analyses by removing a subset of SNPs that were associated with potential confounders. These were identified by having a Bonferroni-corrected P < 1×10-5 for 520 SNPs tested in nine traits; smoking (four traits), alcohol intake (two traits), coffee/tea consumption (two traits), and height (one trait). In addition, to test for the presence of directional pleiotropy, we used two approaches: (1) we created funnel plots for the MR estimates for all SNPs used as instrumental variable, where asymmetry in the funnel plots indicates directional pleiotropy; and (2) we used the MR Egger regression approach where a non-zero intercept indicates presence of directional pleiotropy.2","1x10-8","Not discussed","Not discussed","Not discussed",NA,"520",NA,"520",NA,"Not discussed",NA,"Inverse variance weighted (fixed effects)","Re-ran analysis using subset of SNPs, having removed SNPs associated with potential confounders","Funnel plot","MR Egger",NA,NA,"We repeated the analyses by removing a subset of SNPs that were associated with potential confounders. These were identified by having a Bonferroni-corrected P < 1×10-5 for 520 SNPs tested in nine traits; smoking (four traits), alcohol intake (two traits), coffee/tea consumption (two traits), and height (one trait). In addition, to test for the presence of directional pleiotropy.","r2 (7%) and F statistic","Not discussed","Not discussed","Not discussed","No","No","SD","case/control","OR","1.33",NA,"95","0.96","1.84","8.95x10-2",NA,NA,"Did not investigate the causal effect of obesity as a dichotomous risk factor. MR model assumed a linear relationship between genetically predicted BMI with cancer risk and mortality. Did not investigate the effect of BMI on cancer mortality in prevalent and incident cancers, separately. Overall cancer phenotype may be rather hetero- geneous","Not discussed","Used a homogenous population with all the participants being of white-British ancestry","Statistical power was quite low for a conclusive interpretation of the non-significant individual cancer results",NA,969
